Skip to main content
SpringerLink
Log in

Growth factor and sex steroid interactions in breast cancer

  • Published:
Journal of Mammary Gland Biology and Neoplasia Aims and scope Submit manuscript

Abstract

Mitogenic and inhibitory growth factors and steroid ovarian hormones play important roles as selective modulators of normal mammary development and in the onset and the progression of human breast cancer. The focus of this article is to review past and current research on the interactions of these two classes of effectors in mammary gland development and neoplasia. Steroid hormones regulate synthesis of growth stimulatory and inhibitory growth factors, growth factor receptors, and growth factor binding proteins. In turn, growth factor pathways may modulate phosphorylation and function of steroid receptors and potentiate or inhibit the mitogenic actions of steroids. Ultimately, during the progression of the malignant mammary epithelial cell to hormonal autonomy, overexpression, mutation, or disregulation of key elements of growth factor signal transduction pathways all may play critical roles.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. C. W. Daniel and G. B. Silberstein (1987). Postnatal development of the rodent mammary gland. In M. C. Neville and C. W. Daniel (eds.),The Mammary Gland: Development, Regulation, and Function, Plenum Press, New York, pp. 3–36.

    Google Scholar 

  2. N. Kenney, H. Hosick, G. Herrington, and G. H. Smith (1995). The aged mouse mammary gland. In G. Duagworth (ed.),The Pathobiology of the Aging Mouse, ICSI Press, Hanover, Germany (in press).

    Google Scholar 

  3. S. A. Pringent and N. R. Lemoine (1992). The type-1 (EGFR-related) family of growth factor receptors and their ligands.Prog. Growth Factor Res. 4:1–24.

    PubMed  Google Scholar 

  4. N. Hynes (1996). ErbB2 activation and signal transduction in normal and malignant mammary cells.J. Mam. Gland Biol. Neoplasia 1(2):199–206.

    Google Scholar 

  5. S. Coleman, G. B. Silberstein, and C. W. Daniel (1988). Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor.Dev. Biol. 127:304–315.

    PubMed  Google Scholar 

  6. R. B. Dickson and M. E. Lippman (1991). Growth regulation of normal and malignant breast epithelium. In K. I. Bland and E. M. Copeland (eds.),The Breast, W.B. Saunders, Philadelphia, pp. 363–394.

    Google Scholar 

  7. S. M. Snedeker, C. Brown, and R. P. DiAugustine (1991). Expression and functional properties of transforming growth factor α and epidermal growth factor during mouse mammary gland ductal morphogenesis.Proc. Natl. Acad. Sci. U.S.A. 88:276–280.

    PubMed  Google Scholar 

  8. D. S. Salomon, R. B. Dickson, N. Normanno, T. Saeki, N. Kim, N. Kenney, and F. Ciardiello (1992). Interaction of oncogenes and growth factors in colon and breast cancer. In D. A. Spandidos (ed.),Current Perspectives on Molecular and Cellular Oncology, London, JAI Press Ltd., pp. 211–261.

    Google Scholar 

  9. D. M. Parham and J. Jankowski (1992). Transforming growth factor α in epithelial proliferative diseases of the breast.J. Clin. Pathol. 45:513–516.

    PubMed  Google Scholar 

  10. B. K. Vonderhaar (1993). Local effects of cholesterol carrier system on binding of lactogens and epidermal growth factor to the developing mammary gland.Endocrinology 133:427–429.

    PubMed  Google Scholar 

  11. C. Jhappan, C. Stahle, R. N. Harkins, N. Fausto, G. H. Smith, and G. T. Merlino (1990). TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas.Cell 61:1137–1146.

    PubMed  Google Scholar 

  12. E. P. Sandgren, N. C. Luetteke, R. D. Palmiter, R. L. Brinster, and D. C. Lee (1990). Overexpression of TGFα in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia and carcinoma of the breast.Cell 61:1121–1135.

    PubMed  Google Scholar 

  13. M. Shoyab, U. L. McDonald, J. G. Bradley, and G. J. Todero (1988). Amphiregulin: a bi-functional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7.Proc. Natl. Acad. Sci. U.S.A. 85:6528–6532.

    PubMed  Google Scholar 

  14. N. J. Kenney, R. Huang, G. Johnson, D. Okamura, W. Matheny, G. Plowman, G. H. Smith, D. S. Salomon, and E. D. Adamson (1995). Detection and location of amphiregulin and cripto-1 in the developing mouse mammary gland.Mol. Reprod. Dev. 41:277–286.

    PubMed  Google Scholar 

  15. N. Kenney, G. Johnson, M. P. Selwin, N. King, C. Qi, T. Saeki, R. Brandt, B. Jones, F. Ciardiello, M. Shoyab, G. Plowman, A. Day, D. S. Salomon, and N. Normanno (1993). Transforming growth factor (TGFα) and amphiregulin (AR) as autocrine growth factors in non-transformed, immortalized 184A1N4 human mammary epithelial cells.Mol. Cell. Diff. 1:163–184.

    Google Scholar 

  16. N. J. Kenney, G. H. Smith, and R. B. Dickson (1995). Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland (submitted).

  17. N. J. Kenney, G. H. Smith, W. J. Muller, J. Green, R. H. Callahan, D. S. Salomon, and R. B. Dickson (1995). Detection of amphiregulin and cripto-1 in mammary tumors from transgenic mice.Mol. Carcinog. (in press).

  18. A. Ciccodicola, R. Dono, S. Obici, A. Simeone, M. Zollo, and M. G. Persico (1989). Molecular characterization of a gene of the EGF family expressed in undifferentiated human NTERA2 teratocarcinoma cells.EMBO 8:1987–1991.

    Google Scholar 

  19. R. Brandt, N. Normanno, W. J. Gullick, R. Harkins, D. Scheider, B. Jones, F. Ciardiello, N. Kim, and D. S. Salomon (1994). Physiochemical and biological characterization of human cripto-1: a novel epidermal growth factor-related protein.J. Biol. Chem. 269:17320–17328.

    PubMed  Google Scholar 

  20. N. Kenney (submitted).

  21. G. H. Smith, R. Sharp, E. Kordon, C. Jhappan, and G. Merlino (1995). Transforming growth factor a promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.Am. J. Pathol. (in press).

  22. G. R. Merlo, F. Basolo, L Duboc, and N. E. Hynes (1995). p53-dependent and p53 independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin.J. Cell Biol. 128:1185–1196.

    PubMed  Google Scholar 

  23. R. B. Dickson and M. E. Lippman (1995). Growth factors and breast cancerEndocrine Rev. 16:559–589.

    Google Scholar 

  24. S. D. Robinson, G. B. Silberstein, A. B. Roberts, K. C. Flanders, and C. W. Daniel (1991). Regulated expression and growth inhibitory effects of transforming growth factor-b-isoforms in mouse mammary gland development.Development 113:867–878.

    PubMed  Google Scholar 

  25. G. B. Silberstein and C. W. Daniel (1987). Reversible inhibition of mammary gland growth by transforming growth factor-β.Science 237:291–293.

    PubMed  Google Scholar 

  26. E. C. Kordon, R. A. McKnight, C. Jhappan, L. Hennighausen, G. Merlino, and G. H. Smith (1995). Ectopic TGFβ1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population.Dev. Biol. 168:47–61.

    PubMed  Google Scholar 

  27. C. Knabbe, L. Wakefield, K. Flanders, A. Kasid, R. Derynck, M. E. Lippman, and R. B. Dickson (1987). Evidence that TGF beta is a hormonally regulated negative growth factor in human breast cancer.Cell 48:417–428.

    PubMed  Google Scholar 

  28. M. R. Stampfer, P. Yaswen, M. Alhadeff, and J. Hosoda (1993). TGFβ induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effects.J. Cell Physiol. 155:210–221.

    PubMed  Google Scholar 

  29. C. L. Artega, A. K. Tandon, D. D. Von Hoff, and C. K. Osborne (1988). Transforming growth factor β: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.Cancer Res. 48:3898–3904.

    PubMed  Google Scholar 

  30. J. Massague (1992). Receptors for the TGFβ family.Cell 69:1067–1070.

    PubMed  Google Scholar 

  31. L. S. Mathews (1994). Activin receptors and cellular signaling by the receptor serine kinase family.Endocrine Rev. 15:310–325.

    Google Scholar 

  32. T. Wang, P. K. Donahoe, and A. S. Zervos (1994). Specific interaction of type I receptors of the TGFβ family with the immunophilin FKBP-12.Science 265:674–676.

    PubMed  Google Scholar 

  33. S. M. Gorsch (1992). Immunohistochemical staining for transforming growth factor beta associates with disease progression in human breast cancer.Cancer Res. 52:6949–6952.

    PubMed  Google Scholar 

  34. C. L. Arteaga, T. Carty-Dugger, H. L. Moses, S. D. Hurd, and J. A. Pietenpol (1993). Transforming growth factor β1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice.Cell Growth Diff. 4:193–201.

    PubMed  Google Scholar 

  35. C. W. Daniel, G. B. Silberstein, and P. Strickland (1987). Direct action of 17β-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography.Cancer Res. 47:6052–6057.

    PubMed  Google Scholar 

  36. S. A. Haslam and K. A. Nummy (1992). The ontogeny and cellular distribution of estrogen receptors in normal mouse mammary gland.J. Ster. Biochem. Mol. Biol. 42:589–595.

    Google Scholar 

  37. G. Zugmaier, C. Knabbe, C. Fritsch, S. Simpson, B. Ennis, M. E. Lippman, and R. B. Dickson (1991). Tissue culture conditions determine the effects of estrogen and growth factors on the anchorage independent growth of human breast cancer cell lines.J. Ster. Biochem. Mol. Biol. 39:681–685.

    Google Scholar 

  38. B. Van Der Burg, E. Kulkhoven, L. Isbruecken, and S. W. DeLaat (1992). Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor-defined conditions.J. Ster. Biochem. Mol. Biol. 42:457–465.

    Google Scholar 

  39. S. Neuenschwander, C. T. Roberts, and D. LeRoith (1995). Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid.Endocrinology 136:4298–4303.

    PubMed  Google Scholar 

  40. S. Z. Haslam (1991). Stromal-epithelial interactions in normal and neoplastic mammary gland. In M. Lippman and R. B. Dickson (eds.),Regulatory Mechanisms in Breast Cancer, Kluwer, Boston, pp. 401–420.

    Google Scholar 

  41. S. Z. Haslam, L. J. Counterman, and K. A. Nummy (1993). Effects of epidermal growth factor, estrogen, and progestin on DNA synthesis in mammary cellsin vivo are determined by the developmental state of the gland.J. Cell. Phys. 155:72–84.

    Google Scholar 

  42. E. Musgrove, C. L. Lee, R. L. Sutherland (1991). Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor α, epidermal growth factor receptor, c-fos, and c-myc genes.Mol. Cell Biol. 11:5032–5043.

    PubMed  Google Scholar 

  43. S. C. Kiley, J. Welsh, C. J. Narvaez, and S. Jaken (1996). Protein kinaseC Isozymes and substrates in mammary carcinogenesis.J. Mam. Gland Biol. Neoplasia 1(2):177–187.

    Google Scholar 

  44. S. E. Bates, N. E. Davidson, E. M. Valverius, R. B. Dickson, C. E. Freter, J. P. Tam, and D. S. Salomon (1988). Expression of transforming growth factor alpha and its mRNA in human breast cancer: its regulation by estrogen and its possible functional significance.Mol. Endocrinol. 2:543–555.

    PubMed  Google Scholar 

  45. S. C. Liu, B. Sanfilippo, I. Perroteau, R. Derynck, D. S. Salomon, and W. R. Kidwell (1987). Expression of transforming growth factor α (TGFα) in differentiated rat mammary tumors: estrogen induction of TGFα production.Mol. Endocrinol. 1:683–692.

    PubMed  Google Scholar 

  46. R. B. King, D. Y. Wang, R. J. Daley, and P. D. Darbre (1989). Approaches to studying the role of growth factors in the progression of breast tumors from the steroid sensitive to insensitive state.J. Steroid Biochem. 34:133–138.

    PubMed  Google Scholar 

  47. S. E. Bates, M. E. McManaway, M. E. Lippman, and R. B. Dickson (1986). Characterization of estrogen responsive transforming activity in human breast cancer cell lines.Cancer Res. 46:1707–1713.

    PubMed  Google Scholar 

  48. S. R. Ahmed, B. Badger, C. Wright, and A. Manni (1991). Role of transforming growth factor-α (TGF-α) in basal and hormone-stimulated growth by estradiol, prolactin and progesterone in human and rat mammary tumor cells: studies using TGF-α and EGF receptor antibodies.J. Ster. Biochem. Mol. Biol. 38:687–693.

    Google Scholar 

  49. R. B. Dickson, K. K. Huff, E. M. Spencer, and M. E. Lippman (1986). Induction of epidermal growth factor-related polypeptides by 17-beta estradiol in MCF-7 human breast cancer cells.Endocrinology 118:138–142.

    PubMed  Google Scholar 

  50. R. B. Dickson, M. McManaway, and M. E. Lippman (1986). Estrogen induced factors of breast cancer cells partially replace estrogen to promote tumor growth.Science 232:1540–1543.

    PubMed  Google Scholar 

  51. R. B. Dickson, and M. E. Lippman (1988). Control of human breast cancer by estrogen, growth factors, and oncogenes. In M. E. Lippman, and R. B. Dickson (eds.),Breast Cancer: Cellular and Molecular Biology, Kluwer, Boston, pp. 119–165.

    Google Scholar 

  52. T. Saeki, A. Cristiano, M. J. Lynch, M. Brattain, N. Kim, N. Normanno, N. J. Kenney, and D. S. Salomon (1991). Regulation by estrogen through the 5′-flanking region of the transforming growth factor α gene.Mol. Endocrinol. 5:1955–1963.

    PubMed  Google Scholar 

  53. I. Martinez-Lacaci, M. Saceda, G. Plowman, D. S. Salomon, and R. B. Dickson (1995). Regulation of amphiregulin gene expression by 12-O-tetradecanoylphorbol-13-acetate and 17-β-estradiol in human breast cancer cell lines.Endocrinology 136:3983–3992.

    PubMed  Google Scholar 

  54. A. A. Colleta, L. M. Wakefield, F. V. Howell, D. Danielpour, M. Baum, and M. B. Sporn (1991). The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta.J. Clin. Invest. 87:277–283.

    PubMed  Google Scholar 

  55. L. C. Murphy and H. Dotzlau (1989). Regulation of transforming growth factor β messenger ribonucleic acid abundance in T47D human breast cancer cells.Mol. Endocrinol. 3:611–617.

    PubMed  Google Scholar 

  56. B. A. Arrick, M. Korc, and R. Derynck (1990). Differential regulation of expression of three transforming growth factor-β species in human breast cancer cell lines by estradiol.Cancer Res. 50:299–303.

    PubMed  Google Scholar 

  57. M. E. Herman and B. S. Katzenellenbogen (1994). Alterations in transforming growth factor α and β in production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.Cancer Res. 54:5867–5874.

    PubMed  Google Scholar 

  58. A. Kopp, W. Jonet, M. Schahl, and C. Knabbe (1995). Transforming growth factor β2 (TGFβ2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen.Cancer Res. 55:4512–4515.

    PubMed  Google Scholar 

  59. M. Tzuckerman, X. Zhang, and M. Pfahl (1992). Inhibition of etrogen receptor activity by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate: a molecular analysis.Mol. Endocrinol. 5:1983–1992.

    Google Scholar 

  60. M. Saceda, C. Knabbe, R. B. Dickson, M. E. Lippman, D. Bronzart, R. L. Lindsay, M. Gottardis, and M. B. Martin (1991). Posttranscriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-o-tetradecanoylphorbol-13-acetate.J. Biol. Chem. 266:17809–17814.

    PubMed  Google Scholar 

  61. P. B. Joel, A. M. Traish, and D. Lamigan (1995). Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor.Endocrinology 9:1041–1052.

    Google Scholar 

  62. S. M. Aronica and B. S. Katzanellenbogen (1993). Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cAMP, and IGF-I.Mol. Endocrinol. 7:743–752.

    PubMed  Google Scholar 

  63. R. J. Pietras, J. Arboleda, D. M. Reese, N. Wonguipat, M. D. Pegram, L. Romas, C. M. Gorman, M. G. Parker, M. X. Sliwkowski, and D. J. Slamon (1995).HER2 tyrosine kinase pathway target estrogen receptor and promotes hormone-independent growth in human breast cancer cells.Oncogene 10:2435–2446.

    PubMed  Google Scholar 

  64. N. J. Kenney, T. Saeki, M. Gottardis, P. Garcia-Morales, M. P. Martin, H. Rochefort, N. Normanno, N. Kim, F. Ciardiello, and D. S. Salomon (1993). Expression of transforming growth factor α (TGFα) antisense mRNA inhibits estrogen-induced production of TGFα and estrogen-induced production of TGFα and estrogen-induced growth of estrogen-responsive human breast cancer cells.J. Cell. Physiol. 156:497–514.

    PubMed  Google Scholar 

  65. K. B. Reddy, D. Yee, S. G. Hilsenbeck, R. J. Coffey, and C. K. Osborne (1994). Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor α expression.Cell Growth Diff. 5:1215–1282.

    PubMed  Google Scholar 

  66. I. Kim, A. Manni, J. Lynch, and J. M. Hammond (1991). Identification and regulation of insulin-like growth factor binding proteins produced by hormone-dependent and independent human breast cancer cell lines.Mol. Cell. Endocrinol. 78:71–78.

    PubMed  Google Scholar 

  67. A. J. Stewart, M. D. Johnson, F. E. May, and B. R. Westley (1990). Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells.J. Biol. Chem. 265:21172–21178.

    PubMed  Google Scholar 

  68. K. J. Cullen, M. E. Lippman, D. Chow, S. Hill, N. Rosen, and J. A. Zwiebel (1992). Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression.Mol. Endocrinol. 6:91–100.

    PubMed  Google Scholar 

  69. Clarke, N. Brunner, D. Katz, P. Glanz, R. B. Dickson, M. E. Lippman, and F. G. Kern (1989). The effects of a constitutive production of TGFα on the growth of MCF-7 human breast cancer cellsin vitro andin vivo.Mol. Endocrinol. 3:372–380.

    PubMed  Google Scholar 

  70. S. W. McLeskey, J. Kurebayaski, S. F. Honig, J. Zweibel, M. E. Lippman, R. B. Dickson, and F. G. Kern (1993). Fibroblast growth factor-4 transfection of MCF-7 cells produce cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.Cancer Res. 53:2168–2177.

    PubMed  Google Scholar 

  71. L. C. Murphy, L. J. Murphy, D. Dubik, G. I. Bell, and R. Shiu (1988). Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins.Cancer Res. 48:4555–4560.

    PubMed  Google Scholar 

  72. M. T. Travers, P. Barrett, U. Berger, Y. A. Luqmani, J. Gazet, T. J. Powles, and R. C. Coombes (1988). Growth factor expression in normal, benign, and malignant breast tissue.Br. Med. J. 296:1621–1630.

    Google Scholar 

  73. K. Stromberg, R. Hudgins, and D. N. Orth (1987). Urinary TGFs in neoplasia: immunoreactive TGFα in the urine of patients with disseminated breast carcinoma.Biochem. Biophys. Res. Commun. 144:1059–1067.

    PubMed  Google Scholar 

  74. C. L. Artega, A. R. Hanauske, C. M Clark, C. K. Osborne, P. Hazarika, and R. L. Pardue (1988). Immunoreactive alpha transforming growth factor (IrαTGF) activity in effusions from cancer patients: a marker of tumor burden and patient prognosis.Cancer Res. 48:5023–5028.

    PubMed  Google Scholar 

  75. M. Sairenji, K. Suzuki, K. Murakami, H. Motohashi, T. Okamoto, and M. Umeda (1997). Transforming growth factor activity in pleural and peritoneal effusions from cancer and non-cancer patients.Jpn. J. Cancer Res. (Gann) 78:814–817.

    Google Scholar 

  76. C. Qi, D. S. Liscia, G. Merlo, N. Normanno, G. Johnson, W. J. Gullick, F. Ciardiello, R. Brandt, N. Kim, N. Kenney, and D. S. Salomon (1994). Expression of transforming growth factor a, amphiregulin and cripto-1 in human breast carcinomas.Brit. J. Cancer 69:903–910.

    PubMed  Google Scholar 

  77. S. LeJeune, R. Leck, E. Horak, G. Plowman, M. Greenall, and A. Harris (1993). Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer.Cancer Res. 53:3597–3602.

    PubMed  Google Scholar 

  78. F. J. Lofts and W. J. Gullick (1992).c-erbB2 amplification and overexpression in human tumors. In R. B. Dickson and M. E. Lippman (eds.),Genes, Oncogenes and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer, Kluwer, Norwell, pp. 161–179.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lombardi Cancer Center, Georgetown University, 20007, Washington, D.C.

    Nicholas J. Kenney & Robert B. Dickson

Authors
  1. Nicholas J. Kenney
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert B. Dickson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kenney, N.J., Dickson, R.B. Growth factor and sex steroid interactions in breast cancer. J Mammary Gland Biol Neoplasia 1, 189–198 (1996). https://doi.org/10.1007/BF02013642

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02013642

Key words

Search

Navigation